Prostate cancer cells are also able to convert weaker androgens produced by the adrenal glands, such as androstenedione and dehydroepiandrosterone (DHEA), into testosterone and DHT, which have a higher affinity for AR [14]. This evidence concerns the gene AR and prostate carcinoma.